hsa_var:25v2 : No such data.

KEGG   VARIANT: 25v1
Entry
25v1                      Variant                                  
Name
BCR-ABL1 fusion
Gene
ABL1  ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619]
Organism
hsa_var Human gene variants (Homo sapiens)
Variation
translocation t(9;22)(q34;q11)
COSF: 1756 1758 1783
Variation
TKI-resistant mutations T315I E255V E255K Y253H F311L M351T
OmimVar: 189980
Network
nt06210  ERK signaling (cancer)
nt06214  PI3K signaling (cancer)
nt06219  JAK-STAT signaling (cancer)
nt06276  Chronic myeloid leukemia
Disease
H00004  Chronic myeloid leukemia
Drug target
Asciminib (DG03004): D11403 D11404<JP/US>
Bafetinib: D10202
Bosutinib (DG00718): D09728<JP/US>
Dasatinib (DG00714): D03658<JP> D06414<JP/US> D12609
Imatinib (DG00710): D01441<JP/US> D08066
Nilotinib (DG00716): D06413<JP/US> D08953 D12444 D12854
Olverembatinib: D12175
Ponatinib (DG00722): D09950 D09951<JP/US>
Rebastinib (DG01368): D10334 D10399
Tozasertib (DG01365): D08279 D08344
Vodobatinib: D11786
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:12476301
  Authors
Salesse S, Verfaillie CM
  Title
BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia.
  Journal
Oncogene 21:8547-59 (2002)
DOI:10.1038/sj.onc.1206082
Reference
PMID:17496200
  Authors
O'Hare T, Eide CA, Deininger MW
  Title
Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia.
  Journal
Blood 110:2242-9 (2007)
DOI:10.1182/blood-2007-03-066936
LinkDB

DBGET integrated database retrieval system